David Luci
FounderFounder at Acurx Pharmaceuticals
San Francisco, California, United States
FoundedAcurx Pharmaceuticals
About
David Luci is co-founder, President, and CEO of Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP), a clinical-stage biopharmaceutical company focused on antibiotic drug development, and previously served as its Managing Partner and Director from February 2018. He was formerly President and CEO of Dipexium Pharmaceuticals (Nasdaq: DPRX) through its $69 million merger with PLx Pharma Inc., a board member of Abeona Therapeutics, and President and board member of MacroChem, and he held executive roles at Bioenvision, Inc. Luci began his career as a CPA at Ernst & Whinney LLP and later practiced corporate law at Paul Hastings LLP; he holds a B.S. in Business Administration from Bucknell University and a law degree from Albany Law School of Union University.
Founder at Acurx Pharmaceuticals
Co-founders at Acurx Pharmaceuticals
Experience
- Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP)President and Chief Executive Officercurrent2017 — presentNew York City Metropolitan Area
- Digital Prime TechnologiesChairmancurrent2019 — presentNew York City Metropolitan Area
- Ameri Holdings, Inc.Chairman of the Board of Directors2018 — 2019
- PLx Pharma Inc.Director2017
- Dipexium PharmaceuticalsPresident & CEO, Director2010 — 2017
- Access Pharmaceuticals, Inc.Director2007 — 2010New York, New York
- MacroChem CorporationPresident & Director2007 — 2009New York, New York
- Bioenvision, Inc. (Nasdaq: BIVN)Executive Vice President, CFO and General Counsel2002 — 2007New York, New York
- Paul, Hastings, Janofsky & Walker LLPCorporate Attorney1994 — 2002
- Ernst & Young LLPSenior Auditor1988 — 1991
Skills & more
+12 more
RestructuringVenture CapitalPrivate PlacementsDivestituresCapital MarketsStart-upsCorporate LawInvestor RelationsNegotiationStrategic PlanningStrategy DevelopmentStrategyLanguages Italian
- CPA, JD
From David's professional profile.
Frequently asked questions
- Who is David Luci?
- David Luci is co-founder, President, and CEO of Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP), a clinical-stage biopharmaceutical company focused on antibiotic drug development, and previously served as its Managing Partner and Director from February 2018. He was formerly President and CEO of Dipexium Pharmaceuticals (Nasdaq: DPRX) through its $69 million merger with PLx Pharma Inc., a board member of Abeona Therapeutics, and President and board member of MacroChem, and he held executive roles at Bioenvision, Inc. Luci began his career as a CPA at Ernst & Whinney LLP and later practiced corporate law at Paul Hastings LLP; he holds a B.S. in Business Administration from Bucknell University and a law degree from Albany Law School of Union University.
- Where does David Luci work?
- David Luci is Founder of Acurx Pharmaceuticals.
- What companies did David Luci found?
- David Luci founded Acurx Pharmaceuticals.
- Where did David Luci go to school?
- David Luci studied at Albany Law School (JD, Law); Bucknell University (BSBA, Accounting and Business).
Founder mafias
Bucknell University mafia14
Also came through, then founded or led a company.
+ 7 more
Same school
Also attended Albany Law School3
Also attended Bucknell University82
+ 76 more
Shared employers
Also worked at Digital Prime Technologies1
Also worked at Paul, Hastings, Janofsky & Walker LLP13
+ 7 more
Also worked at Ernst & Young LLP1,835
%20(1).png)
+ 1,829 more